Assessment and Treatment of Vaginitis
- 11 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 144 (6) , 765-781
Abstract
Vaginitis is the presenting symptom at millions of office visits each year in the United States. Although treatment of sporadic cases is often straightforward, recurrent cases present both diagnostic and treatment challenges. Molecular diagnostic tests are likely superior to in-office microscopy for most clinicians and most cases. In both recurrent bacterial vaginosis and recurrent vulvovaginal candidiasis, national treatment guidelines recommend an extended treatment duration with one of the first-line agents. In cases in which such treatment is not successful, vaginal boric acid is likely the cheapest and easiest alternative option. New antifungal medications offer additional but limited treatment options. Probiotics are not recommended for prevention of vulvovaginal candidiasis; however, vaginal products containing Lactobacillus crispatus may have promise for recurrent bacterial vaginosis. Trichomoniasis should be treated with a 1-week course of metronidazole; this is the only sexually transmitted infection for which treatment recommendations vary by sex. In cases in which patients do not respond to initial treatment, the diagnosis should be reconsidered, and other potential causes such as desquamative inflammatory vaginitis, genitourinary syndrome of menopause, or vulvodynia should be considered.Keywords
This publication has 163 references indexed in Scilit:
- Non-antibiotic treatment of bacterial vaginosis—a systematic reviewArchives of Gynecology and Obstetrics, 2020
- Management of Resistant TrichomoniasisCurrent Infectious Disease Reports, 2019
- Nitroimidazole Resistance in Trichomonas vaginalis InfectionJAMA Internal Medicine, 2019
- Probiotics for vulvovaginal candidiasis in non-pregnant womenCochrane Database of Systematic Reviews, 2017
- The effect of contraceptive methods on reproductive tract infections risk: a cross-sectional study having a sample of 52,481 womenArchives of Gynecology and Obstetrics, 2016
- Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and StillbirthJAMA, 2016
- Vaginal Nystatin Versus Oral Fluconazole for the Treatment for Recurrent Vulvovaginal CandidiasisMycopathologia, 2014
- Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New InsightsCurrent Infectious Disease Reports, 2010
- Clinical Spectrum of Desquamative Inflammatory VaginitisCurrent Infectious Disease Reports, 2010
- Two Cases of Vaginitis Caused by Itraconazole-Resistant Saccharomyces cerevisiae and a Review of Recently Published StudiesMycopathologia, 2008